Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Central Nervous System Neoplasms, Malignant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00509301
What this trial is testing

Safety & Radiation Distribution Study of Cotara® in Patients With Recurrent Glioblastoma Multiforme

Who this might be right for
Recurrent Glioblastoma Multiforme
Peregrine Pharmaceuticals 12
Not applicableLooking for participantsNCT07632092
What this trial is testing

Early [18F]-FDG PET Dynamic Analysis in Brain Metastases After Radiotherapy.

Who this might be right for
Short Time ExaminationBrain MetastasesRadiation Necrosis
Centre Hospitalier Universitaire, Amiens 50
Not applicableActive Not RecruitingNCT07447544
What this trial is testing

Predictive Factors for CNS Metastases in Early Breast Cancer Using Liquid Biopsy (AKRA CŽS)

Who this might be right for
Breast CancerCentral Nervous System Metastases
Institute of Oncology Ljubljana 22
Not applicableLooking for participantsNCT04863612
What this trial is testing

SBRT in the Management of Solid Spinal Metastases

Who this might be right for
Extradural TumorSpinal Metastases
Universitaire Ziekenhuizen KU Leuven 100
Not applicableStudy completedNCT05984667
What this trial is testing

C-SMART: Cognitive Strategies, Mindfulness, and Rehabilitation Therapy for Patients With Primary Brain Tumors

Who this might be right for
Glioma, MixedMild Neurocognitive DisorderBrain Tumor
Virginia Commonwealth University 32
Not applicableActive Not RecruitingNCT03665064
What this trial is testing

Long Term Outcome Study in Patients With Pituitary Disorders

Who this might be right for
Pituitary DiseasesPituitary Neoplasms
University of Alberta 1,500
Testing effectiveness (Phase 2)Study completedNCT03274375
What this trial is testing

Immunoadsorption Therapy in Managing NMDAR Antibodies Encephalitis

Who this might be right for
Anti-NMDAR Encephalitis
Assistance Publique - Hôpitaux de Paris 20
Not applicableEnrolling By InvitationNCT06605612
What this trial is testing

Development and Validation of the FBIndex to Determine the Risk of Falls for Patients With Neuromuscular Disorders

Who this might be right for
Inclusion Body MyositisMyotonic DystrophyLimb-girdle and Facioscapulohumeral Muscular Dystrophies+9 more
LMU Klinikum 108
Post-approval studies (Phase 4)Study completedNCT00576472
What this trial is testing

Learning Impairments Among Survivors of Childhood Cancer

Who this might be right for
Acute Lymphoblastic LeukemiaBrain Tumors
St. Jude Children's Research Hospital 469
Not applicableNot Yet RecruitingNCT07034365
What this trial is testing

Risk and Prognosis of Brain Metastasis in Non-Small Cell Lung Cancer

Who this might be right for
NSCLC (Non-small Cell Lung Cancer)Brain Metastases From Non-small Cell Lung Cancer (NSCLC)
Fudan University 2,000
Early research (Phase 1)Study completedNCT00994071
What this trial is testing

A Phase I Study of ABT-888, an Oral Inhibitor of Poly(ADP-ribose) Polymerase and Temozolomide in Children With Recurrent/Refractory CNS Tumors

Who this might be right for
MedulloblastomaPontine GliomaEpendymoma+2 more
National Cancer Institute (NCI) 9
Not applicableStudy completedNCT04178330
What this trial is testing

Tomotherapy as Primary Radiotherapy for Multipule Brain Metastases

Who this might be right for
Brain Metastases
Chinese Academy of Medical Sciences 82
Not applicableLooking for participantsNCT04075305
What this trial is testing

The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study

Who this might be right for
OncologyBreast CancerProstate Cancer+35 more
UMC Utrecht 8,000
Not applicableLooking for participantsNCT04073966
What this trial is testing

MRI Biomarkers for Radiation-Induced Neurocognitive Decline Following SRS of Newly Diagnosed Brain Mets

Who this might be right for
Brain MetastasesNeurocognitive DeficitWhite Matter Alterations+1 more
UNC Lineberger Comprehensive Cancer Center 20
Not applicableActive Not RecruitingNCT06817122
What this trial is testing

The "Let's Talk Tech" Tool to Support Decision Making About Technology Use

Who this might be right for
Dementia, MildMild Cognitive Impairment (MCI)
University of Washington 240
Early research (Phase 1)Active Not RecruitingNCT06958939
What this trial is testing

The Safety and Efficacy of S103 in the Treatment of Refractory Generalized Myasthenia Gravis

Who this might be right for
Myasthenia Gravis, Generalized
Ting Chang, MD 10
Testing effectiveness (Phase 2)Looking for participantsNCT07623577
What this trial is testing

Sac-TMT Combined With Bevacizumab in TNBC With Brain Metastases

Who this might be right for
TNBCBrain Metastasis
Fudan University 24
Testing effectiveness (Phase 2)Study completedNCT02898012
What this trial is testing

Temozolomide Plus Bevacizumab in Supratentorial Glioblastoma in 70 Years and Older Patients With an Impaired Functional Status

Who this might be right for
Glioblastoma MultiformePrimary Brain Tumor
Assistance Publique - Hôpitaux de Paris 70
Not applicableStudy completedNCT00255671
What this trial is testing

Acute Side Effects in Patients Who Are Undergoing Stereotactic Radiosurgery for Brain Tumors or Other Brain Disorders

Who this might be right for
Brain and Central Nervous System TumorsMetastatic CancerRadiation Toxicity
Case Comprehensive Cancer Center 76
Not applicableActive Not RecruitingNCT03606161
What this trial is testing

Navigated Repetitive Transcranial Magnetic Stimulation in Improving Motor Rehabilitation in Participants With Brain Tumors

Who this might be right for
Brain Neoplasm
M.D. Anderson Cancer Center 32
Next Page